T cells were directly injected into primary tumors, metastatic lymph nodes, pleural spaces, or ascites in combination with intravenous IL-2. active investigation of immunotherapy for GI malignancies, with some promising results. Conclusions To date, monoclonal antibody therapy is the only immunotherapy approved by the US Food and Drug Administration for Continue Reading